BCV
RDY icon

Banque Cantonale Vaudoise’s Dr. Reddy's Laboratories RDY Stock Holding History

Banque Cantonale Vaudoise’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17,680
Closed -$231K – 1374
2021
Q4 		$231K Buy
17,680
+20
+0.1% +$252 0.01% 799
2021
Q3 		$230K Sell
17,660
-315
-2% -$4.2K 0.01% 764
2021
Q2 		$264K Hold
17,975
– – 0.01% 781
2021
Q1 		$221K Buy
17,975
+3,590
+25% +$46.1K 0.01% 751
2020
Q4 		$205K Buy
14,385
+2,075
+17% +$27.9K 0.01% 728
2020
Q3 		$171K Buy
12,310
+45
+0.4% +$536 0.01% 726
2020
Q2 		$130K Sell
12,265
-920
-7% -$9.36K 0.01% 746
2020
Q1 		$106K Buy
13,185
+2,105
+19% +$17.6K 0.01% 757
2019
Q4 		$90K Buy
+11,080
New +$87.5K 0.01% 820

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Banque Cantonale Vaudoise's RDY Position: Q1 2022 in Review

Banque Cantonale Vaudoise sold out of Dr. Reddy's Laboratories (RDY) in Q1 2022, closing a stake of 17,680 shares — an estimated $231K sold.

Banque Cantonale Vaudoise first reported a position in RDY in Q4 2019 and held it in 9 quarters. The position peaked at $264K in Q2 2021. 146 funds tracked by Wall St. Rank hold RDY as of Q1 2022.

  • Banque Cantonale Vaudoise reported no remaining Dr. Reddy's Laboratories position as of Q1 2022 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 17,680 Dr. Reddy's Laboratories shares in Q1 2022, an estimated $231K.
  • Banque Cantonale Vaudoise first reported a position in Dr. Reddy's Laboratories in Q4 2019 and held it in 9 quarters.
  • Banque Cantonale Vaudoise's Dr. Reddy's Laboratories position peaked at $264K in Q2 2021.
  • 146 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2022.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2022, filed 9 May 2022.